Health Canada Confirms that BevCanna’s Canadian Standard Processing Licence is in Final Review Stage

VANCOUVER, British Columbia–(BUSINESS WIRE)–Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to announce that it has moved to the Final Review Stage for a Standard Processing Licence from Health Canada. BevCanna submitted its Site Evidence Package to Health Canada on June 22, 2020 and has…

USA Today’s Golfweek Reports On Professional Golfer Bubba Watson’s Battle With Anxieties; cbdMD Plays Strong Role in his Ongoing Health and Wellness Journey

CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBD PR A), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that USA Today’s GolfWeek published a story on October 28, 2020 about two time Masters Champion, and Team cbdMD Athlete, Bubba Watson, in which Bubba discussed his personal and…

Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Participate in the 2020 MJBizCon Election Forum

DENVER–(BUSINESS WIRE)–Schwazze, formerly operating as Medicine Man Technologies Inc. (OTCQX: SHWZ) (“Schwazze” or “the Company”), today announced that the Company will be featured on a panel focused on the election results and the impact to the cannabis industry at the 2020 MJBizCon Election Forum, held virtually on Wednesday, November 4, 2020. Dan Pabon, General Counsel…

Organigram CEO Joins Canadian Chamber of Commerce Board of Directors

MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company’s Chief Executive Officer, Greg Engel, has accepted a position on the Board of Directors of the Canadian Chamber of Commerce. The Canadian…

Global CBD Gummies Market Industry Analysis, Trends, Market Size and Forecasts to 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “CBD Gummies Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering. The report on the global CBD gummies market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global CBD gummies market to grow with a…

Columbia Care Completes US$20.4 Million Add-On Debt Financing

NEW YORK–(BUSINESS WIRE)–Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced the completion of an add-on debt issuance under its existing senior secured indenture via a private placement (the “Offering”) of 20,000 units (the “Units”) for aggregate gross proceeds of approximately US$20.4 million. Each Unit is…

Fibromyalgia (Fibromyalgia Syndrome) Pipeline Review, H2 2020: Therapeutic Analysis of 18 Companies & Drug Profiles – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Fibromyalgia (Fibromyalgia Syndrome) – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Fibromyalgia – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Fibromyalgia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and…

ManifestSeven Reports Third Quarter 2020 Financial Results

IRVINE, Calif.–(BUSINESS WIRE)–ManifestSeven Holdings Corporation (formerly P&P Ventures Inc.) (“M7” or the “Company”) (CSE: MSVN), California’s first integrated omnichannel platform for legal cannabis, today announced its financial results for the three and nine months ended August 31, 2020. The results follow last month’s listing (“Listing”) of the Company’s common shares on the Canadian Securities Exchange.…

Heritage Cannabis Signs Letter of Intent with IntelGenx for Long-Term Cannabis Filmstrip Supply Agreement

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN)(OTCQX: HERTF) (“Heritage” or the “Company”), today announced that it has executed a binding letter of intent (“LOI”) with IntelGenx Corp. (TSXV:IGX)(OTCQB:IGXT) (“IntelGenx”), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, for the supply of filmstrip products containing CBD (“CBD Filmstrips”) for the…